CINECA IRIS Institutional Research Information System

ROSSELLO, ARMANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.859
AS - Asia 11.006
EU - Europa 7.449
SA - Sud America 1.457
Continente sconosciuto - Info sul continente non disponibili 541
AF - Africa 380
OC - Oceania 20
Totale 40.712
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.209
SG - Singapore 3.087
CN - Cina 2.789
HK - Hong Kong 2.628
IT - Italia 2.408
BR - Brasile 1.192
SE - Svezia 1.180
DE - Germania 948
VN - Vietnam 699
BG - Bulgaria 639
CA - Canada 473
TR - Turchia 472
GB - Regno Unito 471
FR - Francia 461
FI - Finlandia 332
IN - India 304
RU - Federazione Russa 268
UA - Ucraina 263
JP - Giappone 228
KR - Corea 219
SN - Senegal 113
BD - Bangladesh 98
AR - Argentina 92
CH - Svizzera 90
IQ - Iraq 81
MX - Messico 75
AT - Austria 72
ID - Indonesia 61
ZA - Sudafrica 54
PK - Pakistan 51
ES - Italia 50
SA - Arabia Saudita 47
BE - Belgio 46
NL - Olanda 45
NG - Nigeria 42
EC - Ecuador 40
VE - Venezuela 37
CI - Costa d'Avorio 34
CO - Colombia 33
PL - Polonia 33
UZ - Uzbekistan 28
MA - Marocco 24
GR - Grecia 23
KE - Kenya 23
EG - Egitto 22
JM - Giamaica 22
AE - Emirati Arabi Uniti 18
IE - Irlanda 18
MY - Malesia 18
CL - Cile 17
PH - Filippine 17
JO - Giordania 16
TT - Trinidad e Tobago 15
TW - Taiwan 15
CZ - Repubblica Ceca 14
KZ - Kazakistan 14
PY - Paraguay 14
AU - Australia 13
CR - Costa Rica 13
DZ - Algeria 13
TN - Tunisia 13
AZ - Azerbaigian 12
IL - Israele 12
LT - Lituania 12
UY - Uruguay 12
IR - Iran 11
LB - Libano 11
NP - Nepal 11
PT - Portogallo 11
AL - Albania 10
BO - Bolivia 10
ET - Etiopia 10
OM - Oman 10
PA - Panama 10
DO - Repubblica Dominicana 9
PE - Perù 9
DK - Danimarca 8
PS - Palestinian Territory 8
RS - Serbia 8
TH - Thailandia 8
BJ - Benin 7
BY - Bielorussia 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
RO - Romania 7
AO - Angola 6
BB - Barbados 6
SV - El Salvador 6
EU - Europa 5
HU - Ungheria 5
PR - Porto Rico 5
BH - Bahrain 4
BW - Botswana 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
EE - Estonia 3
VI - Stati Uniti Isole Vergini 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 40.127
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.606
Woodbridge 2.210
Ashburn 1.825
Singapore 1.800
Ann Arbor 1.689
Chandler 1.171
Houston 1.135
Fairfield 1.098
Santa Clara 985
San Jose 979
Dallas 738
Shanghai 653
Sofia 637
Milan 584
Beijing 549
Serra 541
Seattle 472
New York 447
Council Bluffs 443
Wilmington 421
Ottawa 360
Cambridge 332
Jacksonville 319
Boardman 316
Izmir 307
Los Angeles 301
Princeton 294
Hefei 277
Lawrence 243
Medford 216
Lauterbourg 214
Nanjing 205
Seoul 204
Tokyo 202
Des Moines 192
Florence 190
Ho Chi Minh City 165
London 149
Dong Ket 126
Istanbul 115
Dakar 113
São Paulo 109
Buffalo 106
Frankfurt am Main 106
Hanoi 103
Bremen 102
Dearborn 100
Redondo Beach 100
Pisa 92
Columbus 84
Nanchang 81
Munich 80
Bern 78
Helsinki 77
Rome 77
The Dalles 72
Redwood City 69
Marseille 60
Vienna 58
Boulder 52
Pune 52
San Diego 50
Rio de Janeiro 49
Hebei 48
Jüchen 45
Kunming 44
Ogden 44
Baghdad 43
Brussels 43
Chicago 41
Nürnberg 41
Orem 41
Lagos 40
Lancaster 37
Shenyang 36
Abidjan 34
Phoenix 33
Changsha 32
Pessac 32
Jakarta 31
Lucca 31
San Francisco 31
Toronto 31
Auburn Hills 30
Belo Horizonte 29
Chennai 29
Tianjin 29
Jiaxing 28
Johannesburg 28
Brasília 27
Guangzhou 27
Norwalk 27
Livorno 26
Nuremberg 26
Tashkent 26
Alessandria 25
Da Nang 25
Dhaka 25
Fuzhou 25
Gif-sur-Yvette 25
Totale 28.795
Salva come PNG Salva come JPEG
Nome #
Strategies to target ADAM17 in disease: From its discovery to the iRhom revolution 1.277
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 262
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 243
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 243
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies 229
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 227
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 226
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 223
ADAMs and ADAMTs selective synthetic inhibitors 221
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators 214
Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles 213
Synthesis and antimicrobial properties of new cepham and penam derivatives with the carboxylic group in the "wrong" ß-configuration 211
ADAM metalloproteinases as potential drug targets 210
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 209
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells 207
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter 207
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 206
Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: synthesis and antiinflammatory properties 204
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide 204
Synthesis and α2-adrenergic activity of 2-[(methyleneamino)oxy]-N-(guanidino)ethaneimines. A bioisosteric replacement of the aryl of guanabenz-type benzylideneaminoguanidine α2-agonists with the [(methyleneamino)oxy]methyl moiety (MAOMM) 202
INHIBITORS OF ZINC PROTEASES THIOARYL SUBSTITUTED AND THEIR USE 202
Synthesis and antimicrobial properties of substituted 3-aminoxy-(E)-2-methoxyiminopropionyl penicillins and cephalosporins 198
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 198
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate-Benzenesulfonamide Conjugates 198
Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds 198
Age-related macular degeneration: Current knowledge of zinc metalloproteinases involvement 197
Ionic liquid-promoted green synthesis of biologically relevant diaryl thioethers 197
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 195
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 194
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors 194
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization 193
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 193
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 193
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 193
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 192
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 190
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 189
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides 188
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 187
Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models 187
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 186
Synthesis of New Classes of MMPs Sugars-Based Inhibitors 186
New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy. 185
N-O-Isopropyl sulfonamido-based hydroxamates: Kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors 184
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 184
Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-a Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models 183
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 183
Exploring the binding of quercetin-3-O-metabolites with transthyretin 182
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 181
Conformationally restrained β -blocking oxime ethers: synthesis and β -adrenergic properties of diastereoisomeric anti and syn 2-(5-isoxazolidinyl)ethanolamines 181
Synthetic analogs of xanthohumol for use in the prevention and​/or treatment of tumors 180
Drug design of sulfonylated MMP inhibitors 179
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 179
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 179
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors 179
Synthesis and adrenergic ß-blocking activity of (oxypropanolamino)-substituted [(benzylideneamino)oxy]propanolamines 178
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2) 177
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion 177
Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives 176
1-(1-pirril)-3- ammino-2-propanoli N-sostituiti: sintesi e proprietà ß-adrenergiche 176
Synthesis and antimicrobial activity of 7ß-(S) and 7ß-(R)-3-(methyleneaminoxy)-2-methylpropionamido substituted cephalosporanic acid derivatives 176
Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines 176
Crystallization of bi-functional ligand protein complexes 174
Inhibitors of A Disintegrin And Metalloproteinases-10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect 174
A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs 173
Synthesis and β-adrenergic properties of tetrahydronaphthalene analogs of dichloroisoproterenol 173
Arylsulfonamide derivatives as metalloproteases inhibitors and their preparation, pharmaceutical compositions and use in the treatment of degenerative disorders 173
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition 172
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 172
Aryl-sulphonamidic dimers as metalloproteases inhibitors 172
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 172
Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening 172
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 171
Synthesis and aldose reductase inhibitory activity of some N-(aroyl)-N-(arylalkyloxy)-glycines and -beta-alanines 170
1-benzilossiimmino-3- ammino-2-propanoli: sintesi e proprietà ß-adrenergiche 169
Role of the benzylic hydroxyl group of adrenergic catecholamines in eliciting a-adrenergic activity. Synthesis and a1- and a2-adrenergic activity of 3-phenyl-3-piperidinols and of their desoxy analogs 168
Conversion reactions of cepham into penam systems. A route to determine the relative configurations of two diastereoisomeric 3-bromo-4-methoxycepham derivatives 168
Compounds with a benzo [a]carbazole structure for use in the prevention and/or treatment of infectious diseases 167
Iminodiacetyl-monohydroxamate derivatives as potent and selective MMP inhibitors 167
Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors 167
In Vivo Imaging of Matrix Metalloproteinase 12 and Matrix Metalloproteinase 13 Activities in the Mouse Model of Collagen-Induced Arthritis 167
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: Enantioselective synthesis and selective inhibition of MMPs 165
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models 165
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 165
Design of selective collagenase 3 (MMP-13) inhibitors as potential therapeutic agents in rheumatoid arthritis 163
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 163
Powerful twin carboxylic inhibitors for MMP homodimerization 160
MMP-8 Is Critical for Dexamethasone Therapy in Alkali-Burned Corneas Under Dry Eye Conditions 160
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease 159
Sintesi, configurazione e proprietà ß-adrenergiche di derivati 1-(5-isossazolidin) 2-amminoetanolici diastereoisomeri 159
Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines. 159
(E)-(ARYLMETHYLENEAMINOXY)ACETAMIDES AS ANALOGS OF NEUROLEPTIC BENZAMIDES - SYNTHESIS AND D-2-DOPAMINERGIC BINDING-AFFINITY 158
New hydroxypyrimidinones as inhibitors of matrix metalloproteinases 157
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 157
Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis 156
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 156
Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity 156
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP 155
3-(4-iodomethyl-2-oxo-1-azetidinyl)propynoic acid t-butyl ester: A new ß-lactam derivative. Synthesis of an ynamide by reaction of 4-iodomethylazetidin-2-one with the t-butyl ester of propiolic acid in the presence of copper (I) 155
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma 155
Totale 19.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.738 0 263 49 144 506 377 66 140 94 77 166 856
2022/20233.731 456 444 254 401 411 466 38 269 649 22 266 55
2023/20242.548 326 279 297 161 369 477 102 82 42 47 135 231
2024/20257.833 39 327 162 441 765 683 787 466 753 1.017 781 1.612
2025/202610.042 769 2.353 1.084 732 811 816 1.356 389 500 755 292 185
2026/2027824 211 613 0 0 0 0 0 0 0 0 0 0
Totale 40.712